Short term growth and hypopituitary-adrenal axis function in children with asthma treated with inhaled beclomethasone dipropionate HFA

O. D. Wolthers (Randers, Denmark)

Source: Annual Congress 2005 - Different aspects of asthma
Session: Different aspects of asthma
Session type: Thematic Poster Session
Number: 3937
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. D. Wolthers (Randers, Denmark). Short term growth and hypopituitary-adrenal axis function in children with asthma treated with inhaled beclomethasone dipropionate HFA. Eur Respir J 2005; 26: Suppl. 49, 3937

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short term growth and hypopituitary-adrenal axis function in asthmatic children treated with inhaled beclomethasone dipropionate HFA with a spacer
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005

Systemic activity of inhaled beclomethasone dipropionate HFA: a comparison of volume spacers
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

HFA beclomethasone dipropionate (HFA-BDP) extrafine aerosol and formoterol in optimizing the management of bronchial asthma at children
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005

Effects of the changing from chlorofluorocarbon (CFC)- beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Effects of inhaled corticosteroids on growth in asthmatic children: A comparision of fluticasone propianate with budesonide
Source: Eur Respir J 2003; 22: Suppl. 45, 133s
Year: 2003

Acceptability and efficacy of beclomethasone dipropionate (Béclojet HFA®) and fluticasone dipropionate (Flixotide HFA®, FDP) associated with the Volumatic® spacer in adults with mild to moderate persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 473s
Year: 2003

Comparative clinical study of addition theophylline to low-dose inhaled beclomethasone dipropionate and medium-dose inhaled beclomethasone dipropionate in patients with mild-to-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001

Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma
Source: Eur Respir J 2004; 24: 932-937
Year: 2004



Health related quality of life evaluation after beclomethasone dipropionate (BDP) treatment in children with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 381s
Year: 2004

Salmeterol and beclomethasone dipropionate versus higher dose beclomethasone dipropionate in asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 124s
Year: 2005

HFA vs CFC beclomethasone dipropionate – comparative effectiveness in asthma management
Source: Eur Respir J 2006; 28: Suppl. 50, 498s
Year: 2006

Impact of age on extra-fine particle hydrofluoroalkane beclometasone dipropionate versus fluticasone propionate outcomes in asthmatic children
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Extrafine beclomethasone dipropionate aerosol therapy shows promising improved effect in treatment of children with stable asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004

Comparison of medium dose inhaled beclomethasone dipropionate (BDP) and low dose inhaled BDP plus sustained-release theophylline in the treatment of patients with moderate persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002

Once daily nebulized beclomethasone in asthmatic children
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005

Comparison of a new extrafine beclomethasone dipropionate HFA134a-formulated pMDI with a standard BDP CFC pMDI in adults with moderate persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Therapeutic equivalence of beclomethasone dipropionate/formoterol administered via NEXTTM DPI with beclomethasone dipropionate/formoterol administered via HFA pMDI in adult asthmatic patients
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Bronchoprotective and anti-inflammatory effect of beclometasone dipropionate plus formoterol HFA fixed combination in asthmatic patients
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

How much inhaled steroid is sufficient? Assessing the relationship between adherence rate to beclomethasone dipropionate and the level of asthma control
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011